Gus D. Warren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Gus D. Warren has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Nicole Loes
University of Oregon
1 shared publication - Joseph L. Harman
Department of Chemistry and Biochemistry, University of Oregon
1 shared publication - Kirsten Jeanne Lampi
Department of Biomaterials and Biomedical Sciences School of Dentistry Oregon Health & Science University Robertson Collaborative Life Sciences Building & Skourtes Tower, 2730 S Moody Ave Portland OR 97239 USA
1 shared publication - Maureen C. Heaphy
University of Oregon
1 shared publication - Michael J. Harms
Institute of Molecular Biology, University of Oregon
1 shared publication
Latest Publications
- Open Access
- 5 December 2019
- Published by Cold Spring Harbor Laboratory in bioRxiv
- p. 865493
Evolution of multifunctionality through a pleiotropic substitution in the innate immune protein S100A9
Multifunctional proteins are evolutionary puzzles: how do proteins evolve to satisfy multiple functional constraints? S100A9 is one such multifunctional protein. It potently amplifies inflammation via Toll-like receptor 4 and is antimicrobial as part of a heterocomplex with S100A8. These two functions are seemingly regulated by proteolysis: S100A9 is readily degraded, while S100A8/S100A9 is resistant. We take an evolutionary biochemical approach to show that S100A9 evolved both functions and lost proteolytic resistance from a weakly proinflammatory, proteolytically resistant amniote ancestor. We identify a historical substitution that has pleiotropic effects on S100A9 proinflammatory activity and proteolytic resistance but has little effect on S100A8/S100A9 antimicrobial activity. We thus propose that mammals evolved S100A8/S100A9 antimicrobial and S100A9 proinflammatory activities concomitantly with a proteolytic “timer” to selectively regulate S100A9. This highlights how the same mutation can have pleiotropic effects on one functional state of a protein but not another, thus facilitating the evolution of multifunctionality.
- 5 December 2019
- Published by Cold Spring Harbor Laboratory in bioRxiv
- p. 865493
Open AccessEvolution of multifunctionality through a pleiotropic substitution in the innate immune protein S100A9
Multifunctional proteins are evolutionary puzzles: how do proteins evolve to satisfy multiple functional constraints? S100A9 is one such multifunctional protein. It potently amplifies inflammation via Toll-like receptor 4 and is antimicrobial as part of a heterocomplex with S100A8. These two functions are seemingly regulated by proteolysis: S100A9 is readily degraded, while S100A8/S100A9 is resistant. We take an evolutionary biochemical approach to show that S100A9 evolved both functions and lost proteolytic resistance from a weakly proinflammatory, proteolytically resistant amniote ancestor. We identify a historical substitution that has pleiotropic effects on S100A9 proinflammatory activity and proteolytic resistance but has little effect on S100A8/S100A9 antimicrobial activity. We thus propose that mammals evolved S100A8/S100A9 antimicrobial and S100A9 proinflammatory activities concomitantly with a proteolytic “timer” to selectively regulate S100A9. This highlights how the same mutation can have pleiotropic effects on one functional state of a protein but not another, thus facilitating the evolution of multifunctionality.